106 related articles for article (PubMed ID: 18475202)
1. In vitro and in vivo pharmacodynamic properties of metoprolol in fructose-fed hypertensive rats.
Di Verniero CA; Silberman EA; Mayer MA; Opezzo JA; Taira CA; Höcht C
J Cardiovasc Pharmacol; 2008 Jun; 51(6):532-41. PubMed ID: 18475202
[TBL] [Abstract][Full Text] [Related]
2. Changes in the in vitro pharmacodynamic properties of metoprolol in atria isolated from spontaneously hypertensive rats.
Di Verniero C; Höcht C; Opezzo JA; Taira CA
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):161-5. PubMed ID: 17250633
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study.
Höcht C; Di Verniero C; Opezzo JA; Bramuglia GF; Taira CA
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jul; 373(4):310-8. PubMed ID: 16733693
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity to diltiazem hypotensive effect in an experimental model of high-renin hypertension.
Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
J Pharm Pharmacol; 2009 Jan; 61(1):79-87. PubMed ID: 19126300
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic antihypertensive effect of metoprolol in chronic aortic coarctated rats.
Höcht C; Opezzo JA; Taira CA
Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):681-6. PubMed ID: 16120197
[TBL] [Abstract][Full Text] [Related]
6. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic properties of metoprolol in chronic aortic coarctated rats.
Höcht C; Di Verniero C; Opezzo JA; Taira CA
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):1-8. PubMed ID: 15300360
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats.
Bertera F; Di Verniero CA; Mayer MA; Chiappetta D; Buontempo F; Polizio AH; Taira CA; Höcht C
Xenobiotica; 2012 Feb; 42(2):206-19. PubMed ID: 21892881
[TBL] [Abstract][Full Text] [Related]
9. Applicability of microdialysis as a technique for pharmacokinetic-pharmacodynamic (PK-PD) modeling of antihypertensive beta-blockers.
Höcht C; DiVerniero C; Opezzo JA; Taira CA
J Pharmacol Toxicol Methods; 2005; 52(2):244-50. PubMed ID: 16125622
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats.
Verma S; Bhanot S; McNeill JH
J Pharmacol Exp Ther; 1994 Dec; 271(3):1334-7. PubMed ID: 7996443
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic modeling of metoprolol stereoisomers in spontaneously hypertensive rat.
Yin XX; Zhang YD; Luo JP; Huang XP; Shen JP; Ding Y; Huang DK
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):104-8. PubMed ID: 10072957
[TBL] [Abstract][Full Text] [Related]
12. Metoprolol succinate combination in the treatment of hypertension.
Papadopoulos DP; Papademetriou V
Angiology; 2009; 60(5):608-13. PubMed ID: 19033265
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic angiotensinergic-noradrenergic systems interaction in fructose induced hypertension.
Mayer MA; Höcht C; Gironacci M; Opezzo JA; Taira CA; Fernández BE; Puyó AM
Regul Pept; 2008 Feb; 146(1-3):38-45. PubMed ID: 17822786
[TBL] [Abstract][Full Text] [Related]
14. Concentration-effect relationship of l-propranolol and metoprolol in spontaneous hypertensive rats after exercise-induced tachycardia.
Brynne L; Karlsson MO; Paalzow LK
J Pharmacol Exp Ther; 1998 Sep; 286(3):1152-8. PubMed ID: 9732372
[TBL] [Abstract][Full Text] [Related]
15. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic-pharmacodynamic modeling of metoprolol enantiomers in the dog].
Yin XX; Zhang YD
Yao Xue Xue Bao; 1997 Jun; 32(6):411-5. PubMed ID: 11596322
[TBL] [Abstract][Full Text] [Related]
17. Methylation of adrenergic β1 receptor is a potential epigenetic mechanism controlling antihypertensive response to metoprolol.
Jiang Q; Yuan H; Xing X; Liu J; Huang Z; Du X
Indian J Biochem Biophys; 2011 Oct; 48(5):301-7. PubMed ID: 22165287
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of the hypertensive response to combretastatin A-4 phosphate in rats.
Ke Q; Bodyak N; Rigor DL; Hurst NW; Chaplin DJ; Kang PM
Vascul Pharmacol; 2009; 51(5-6):337-43. PubMed ID: 19737629
[TBL] [Abstract][Full Text] [Related]
19. The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome.
Leibowitz A; Peleg E; Sharabi Y; Shabtai Z; Shamiss A; Grossman E
Am J Hypertens; 2008 Mar; 21(3):348-51. PubMed ID: 18219301
[TBL] [Abstract][Full Text] [Related]
20. Role of hypothalamic alpha-adrenoceptor activity in fructose-induced hypertension.
Mayer MA; Höcht C; Opezzo JA; Peredo HA; Navacchia D; Taira CA; Fernández BE; Puyó AM
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):904-9. PubMed ID: 17002666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
